Commerce Dashboard
Pharmaceuticals
India ranks 3rd worldwide for pharmaceutical production by volume and 14th by value. The country has an established domestic pharmaceutical industry, with a strong network of 3,000 drug companies and ~10,500 manufacturing units.

Indian Pharmaceuticals Industry Analysis

    Last updated on Jul, 11 2021

Indian pharmaceutical sector supplies over 50% of the global demand for various vaccines, 40% of the generic demand for US and 25% of all medicines for UK. India contributes the second-largest share of pharmaceutical and biotech workforce in the world. According to the Indian Economic Survey 2021, the domestic market is expected to grow 3x in the next decade. India’s domestic pharmaceutical market is estimated at US$ 42 billion in 2021 and likely to reach US$ 65 billion by 2024 and further expand to reach ~US$ 120-130 billion by 2030.

Globally, India ranks 3rd in terms of pharmaceutical production by volume and 14th by value. The domestic pharmaceutical industry includes a network of 3,000 drug companies and ~10,500 manufacturing units.

Indian drugs are exported to more than 200 countries in the world, with US being the key market. Generic drugs account for 20% of the global export in terms of volume, making the country the largest provider of generic medicines globally. It is expected to expand even further in the coming years. The Indian pharmaceutical exports, including bulk drugs, intermediates, drug formulations, biologicals, Ayush & herbal products and surgical, reached US$ 24.44 billion in FY21.

India’s medical devices market stood at US$ 10.36 billion in FY20. The market is expected to increase at a CAGR of 37% from 2020 to 2025 to reach US$ 50 billion.

‘Pharma Vision 2020’ by the Government’s Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery. The Indian drugs and pharmaceuticals sector has received cumulative FDI inflows worth US$ 17.75 billion between April 2000 and December 2020.

To achieve self-reliance and minimise import dependency in the country's essential bulk drugs, the Department of Pharmaceuticals initiated a PLI scheme to promote domestic manufacturing by setting up greenfield plants with minimum domestic value addition in four separate ‘Target Segments’ with a cumulative outlay of Rs. 6,940 crore (US$ 951.27 million) from FY21 to FY30.

Under Union Budget 2021-22, the Ministry of Health and Family Welfare has been allocated Rs. 73,932 crore (US$ 10.35 billion) and the Department of Health Research has been allocated Rs. 2,663 crore (US$ 365.68 billion). The government allocated Rs. 37,130 crore (US$ 5.10 billion) to the 'National Health Mission’. PM Aatmanirbhar Swasth Bharat Yojana was allocated Rs. 64,180 crore (US$ 8.80 billion) over six years. The Ministry of AYUSH was allocated Rs. 2,970 crore (US$ 407.84 million), up from Rs. 2,122 crore (US$ 291.39 million).

India plans to set up a nearly Rs. 1 lakh crore (US$ 1.3 billion) fund to provide boost to companies to manufacture pharmaceutical ingredients domestically by 2023.

Indian Pharmaceuticals Industry Report (May, 2021)
Download PDF Download PDF  (Size: 809.1 KB )

Click to access the Pharmaceuticals Industry Archived Report

IBEF Blog - INDIA ADDA – PERSPECTIVES ON INDIA More

India to become Aatmanirbhar in Phosphatic Fertilisers
IBEF, Knowledge Centre

Introduction
Agriculture, including its allied sector, is the largest s...

Indian agritech sector to grow to US$ 30-35 billion by 2025
IBEF, Knowledge Centre

Overview
India is an agrarian economy, with ~54.6% people directly depe...

Production Linked Incentive (PLI) Scheme for IT Hardware Products
IBEF, Knowledge Centre

Overview
In comparison with capabilities of countries worldwide, India&...

Government Launches Six Tech Innovation Platforms to Enable Globally Competent Manufacturing
IBEF, Knowledge Centre

Overview
India’s manufacturing industry has emerged as one of the...

Role of 'Freight Smart Cities' to Enhance Urban Freight Systems
IBEF, Knowledge Centre

Introduction
India is one of the fastest-growing economies in the world...

Office Space Witnessing Growth in India
IBEF, Knowledge Centre

Market Overview
India is one of the fastest-growing markets for office ...

Case Studies More

JOIN IBEF.org

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member?
Login / Retrieve Password